BioCentury
ARTICLE | Company News

Eisai, Sorrento deal

June 30, 2014 7:00 AM UTC

Eisai’s Morphotek Inc. subsidiary and Sorrento’s Concortis Biosystems Inc. subsidiary partnered to generate antibody-drug conjugates (ADCs) based on a Morphotek antibody linked to chemotherapeutics u...